This collection explores how fit-for-purpose technology and innovation support clinical compliance and inspection readiness. Articles focus on the practical application of digital systems and emerging tools to strengthen oversight, improve data confidence, and enable risk-based approaches within regulated clinical environments.
AI and other next-generation technologies are poised to reshape clinical research as we know it—especially in how we manage clinical data, operations, and compliance. What’s coming isn’t just incremental improvement—it’s transformational. From automated Trial Master File (TMF) oversight to intelligent quality monitoring, these innovations will streamline operations, reduce risk, and elevate compliance to a level that simply isn’t possible with manual processes.
How Generative AI is Transforming GCP Inspection Readiness Just in Time GCP’s Founder and CEO, Donna Dorozinsky, contributed a guest column for Clinical Leader outlining the impact of generative AI on GCP inspection and clinical trial readiness. She describes its transformative potential and how sponsors can prepare today for adoption and integration of AI- driven […]
Generative AI in Clinical Trials At Just in Time GCP, we know the pressure trial sponsors face to stay inspection-ready while managing the quality and completeness of the Trial Master File (TMF). Generative AI is opening new opportunities to address these challenges—helping sponsors balance speed, cost, and compliance while strengthening TMF integrity. Understanding the Challenges […]